Shiqi Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shiqi Wang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Christopher J. Lingle
Department of Anesthesiology, Washington University School of Medicine, St Louis, USA
2 shared publications- Hailan Hu
School of Brain Science and Brain Medicine, New Cornerstone Science Laboratory, Zhejiang University School of Medicine, Hangzhou, China
2 shared publications Haohong Li
Nanhu Brain–Computer Interface Institute, MOE Frontier Science Center for Brain Science and Brain–Machine Integration, State Key Laboratory of Brain–Machine Intelligence, New Cornerstone Science Laboratory, Zhejiang University, Hangzhou, China
2 shared publications- Huan Ma
Department of Neurology of Second Affiliated Hospital and Liangzhu Laboratory, School of Brain Science and Brain Medicine, Zhejiang University School of Medicine, Hangzhou, China
2 shared publications Junying Wang
Nanhu Brain–Computer Interface Institute, MOE Frontier Science Center for Brain Science and Brain–Machine Integration, State Key Laboratory of Brain–Machine Intelligence, New Cornerstone Science Laboratory, Zhejiang University, Hangzhou, China
2 shared publicationsMin Chen
Nanhu Brain–Computer Interface Institute, MOE Frontier Science Center for Brain Science and Brain–Machine Integration, State Key Laboratory of Brain–Machine Intelligence, New Cornerstone Science Laboratory, Zhejiang University, Hangzhou, China
2 shared publications
Latest Publications
- Open Access
- 6 November 2023
- Published by Springer Nature in Nature
- Vol. 623 (7988) , E11
Author Correction: Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb
- 6 November 2023
- Published by Springer Nature in Nature
- Vol. 623 (7988) , E11
Open AccessAuthor Correction: Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb
- Top Cited PapersOpen Access
- 18 October 2023
- Published by Springer Nature in Nature
- Vol. 622 (7984) , 802-809
Sustained antidepressant effect of ketamine through NMDAR trapping in the LHb
Ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist1, has revolutionized the treatment of depression because of its potent, rapid and sustained antidepressant effects2–4. Although the elimination half-life of ketamine is only 13 min in mice5, its antidepressant activities can last for at least 24 h6–9. This large discrepancy poses an interesting basic biological question and has strong clinical implications. Here we demonstrate that after a single systemic injection, ketamine continues to suppress burst firing and block NMDARs in the lateral habenula (LHb) for up to 24 h. This long inhibition of NMDARs is not due to endocytosis but depends on the use-dependent trapping of ketamine in NMDARs. The rate of untrapping is regulated by neural activity. Harnessing the dynamic equilibrium of ketamine–NMDAR interactions by activating the LHb and opening local NMDARs at different plasma ketamine concentrations, we were able to either shorten or prolong the antidepressant effects of ketamine in vivo. These results provide new insights into the causal mechanisms of the sustained antidepressant effects of ketamine. The ability to modulate the duration of ketamine action based on the biophysical properties of ketamine–NMDAR interactions opens up new opportunities for the therapeutic use of ketamine.
- 18 October 2023
- Published by Springer Nature in Nature
- Vol. 622 (7984) , 802-809
Top Cited PapersOpen AccessSustained antidepressant effect of ketamine through NMDAR trapping in the LHb
Ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist1, has revolutionized the treatment of depression because of its potent, rapid and sustained antidepressant effects2–4. Although the elimination half-life of ketamine is only 13 min in mice5, its antidepressant activities can last for at least 24 h6–9. This large discrepancy poses an interesting basic biological question and has strong clinical implications. Here we demonstrate that after a single systemic injection, ketamine continues to suppress burst firing and block NMDARs in the lateral habenula (LHb) for up to 24 h. This long inhibition of NMDARs is not due to endocytosis but depends on the use-dependent trapping of ketamine in NMDARs. The rate of untrapping is regulated by neural activity. Harnessing the dynamic equilibrium of ketamine–NMDAR interactions by activating the LHb and opening local NMDARs at different plasma ketamine concentrations, we were able to either shorten or prolong the antidepressant effects of ketamine in vivo. These results provide new insights into the causal mechanisms of the sustained antidepressant effects of ketamine. The ability to modulate the duration of ketamine action based on the biophysical properties of ketamine–NMDAR interactions opens up new opportunities for the therapeutic use of ketamine.